Drug Shortage Report for TEVA-ECTOSONE
| Report ID | 144715 |
| Drug Identification Number | 00653217 |
| Brand name | TEVA-ECTOSONE |
| Common or Proper name | TEVA-ECTOSONE |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | BETAMETHASONE |
| Strength(s) | 0.1% |
| Dosage form(s) | LOTION |
| Route of administration | TOPICAL TOPICAL |
| Packaging size | 75 |
| ATC code | D07AC |
| ATC description | CORTICOSTEROIDS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2021-08-27 |
| Estimated end date | 2023-11-30 |
| Actual end date | 2023-11-30 |
| Shortage status | Resolved |
| Updated date | 2023-12-05 |
| Company comments | This pack size is now discontinued, and no longer available. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v21 | 2023-12-05 | French | Compare |